Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Nilotinib (AMN-107)

InhA, Func 641571-10-0
Catalog No. ABIN3221384
  • Application
    Inhibition Assay (InhA), Functional Studies (Func)
    Purpose
    Nilotinib, also known as AMN107, is a tyrosine kinase inhibitor under investigation as a possible treatment for chronic myelogenous leukemia (CML). In June 2006, a Phase I clinical trial found nilotinib has a relatively favorable safety profile and shows activity in cases of CML resistant to treatment with imatinib (Gleevec®), another tyrosine kinase inhibitor currently used as a first-line treatment.
    Characteristics
    Tradename: AMN-107
    Source of Compound: synthetic
    Target: Bcr-Abl inhibitor,Mast/stem cell GFR Kit agonist
    Receptor: Bcr-Abl ,Mast/stem cell GFR Kit
    Purification
    All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
    Purity
    99.00 %
    Formula
    C28H22F3N7O
    Solubility
    DMSO 27 mg/Ml,Water <1 mg/mL
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Solid
    Storage
    -20 °C
    Storage Comment
    For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
    Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
    Several freeze/thaw cycles should not damage the activity of our small molecule products.
    However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours.
    Expiry Date
    24 months
  • Background
    Tyrosine Kinase/Adaptors
    Molecular Weight
    529.52 g/mol
    CAS-No
    641571-10-0
You are here:
Support